DAYTON, Ohio (WDTN) — After more than a two-year hiatus, Kroger is welcoming back Express Scripts customers for health and pharmacy needs. Kroger announced Feb. 5 that an agreement has been reached ...

Add Yahoo as a preferred source to see more of our stories on Google. Two dozen Democrat and Republican lawmakers have raised issues about Express Scripts, the company that oversees the U.S.

Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Express ...

Express Scripts Inc. knows what it means to be a good neighbor, and they have proven that with $4 million in gifts to the University of Missouri-St. Louis since announcing in 2005 that the company was ...

On the heels of a similar announcement from Optum Rx, pharmacy benefit management giant Express Scripts said Monday that it will add three biosimilars to its formulary to compete with Humira. The PBM ...

Retail pharmacies are accusing Express Scripts and Prime Therapeutics of monopolizing the pharmacy benefit manager market and conspiring to extort pharmacies, according to court documents. The two ...

ST. LOUIS — Supermarket operators are preparing for an uptick in pharmacy business as Walgreens was scheduled to end its contract with pharmacy benefits manager Express Scripts on Jan. 1. "Many ...

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action "The fact is that in the unlikely event the ...

Express Scripts will partner with CPESN in the latest evolution of its IndependentRx Initiative, which aims to boost independent and community pharmacies. The pharmacy benefit manager announced ...

Express Scripts will include Cyltezo and both Sandoz products (Hyrimoz and unbranded adalimumab-adaz) – inflammatory disease biosimilars with competitive net costs – as preferred products on the ...

Express Scripts, the pharmacy benefits management business of the Cigna Group's Evernorth, will add three additional biosimilars to its National Preferred Formulary that it said will compete with ...